Acorda Therapeutics Return on Assets:
31.32% for Dec. 31, 2012Acorda Therapeutics Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 31.32% |
| Dec. 31, 2012 | 36.13% |
| Sept. 30, 2012 | 8.98% |
| June 30, 2012 | 11.84% |
| March 31, 2012 | 10.93% |
| Dec. 31, 2011 | 8.77% |
| Sept. 30, 2011 | 6.36% |
| June 30, 2011 | 4.61% |
| March 31, 2011 | 2.67% |
| Dec. 31, 2010 | -3.66% |
| Sept. 30, 2010 | -11.83% |
| June 30, 2010 | -21.28% |
| March 31, 2010 | -26.90% |
| Dec. 31, 2009 | -26.76% |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
ACOR Return on Assets Benchmarks
| Companies | |
|---|---|
| Discovery Laboratories | -97.03% |
| Exelixis | -27.71% |
| Achillion Pharmaceuticals | -47.81% |
ACOR Return on Assets Rankings
| Overall |
99th percentile 74 of 7593 |
| Sector |
98th percentile 9 of 650 in Healthcare |
| Industry |
97th percentile 7 of 237 in Biotechnology |
ACOR Return on Assets Range, Past 5 Years
| Minimum | -36.94% | Jun 2008 |
| Maximum | 36.13% | Dec 2012 |
| Average | -8.14% |
